Tagged with japan

Bridging the Open Innovation Gap Between Academia and Pharma in Japan
Shinobu Uzu – Senior Executive Director, PMDA, Japan
Japanese Academic Clinical Data Can Now Be Used for Drug Registration
APAC Pharma Roundup: Celltrion Sells Takeda Portfolio; Novartis Strikes a Deal with Chong Kun Dang
Ensuring Quality in Real-World Data in Japan
Astellas to “Go on the Aggressive” Under New CEO
Japan’s Next-Generation Medical Infrastructure Law: Appropriate Use of Individual Medical Information
Top 10 Japanese Pharma Companies 2022
Japan PMDA Drug Approvals 2022
Pharma R&D in Japan: In Need of an Upgrade
Japan’s New Emergency Regulatory Approval System
Biosimilars & Biologics: Japan
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here